- Home
- MARPS vs ACXP Comparison
MARPS vs ACXP Comparison
Compare MARPS & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARPS
- ACXP
- Stock Information
- Founded
- MARPS 1956
- ACXP 2017
- Country
- MARPS United States
- ACXP United States
- Employees
- MARPS N/A
- ACXP N/A
- Industry
- MARPS Oil & Gas Production
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- MARPS Energy
- ACXP Health Care
- Exchange
- MARPS Nasdaq
- ACXP Nasdaq
- Market Cap
- MARPS 7.5M
- ACXP 8.4M
- IPO Year
- MARPS N/A
- ACXP 2021
- Fundamental
- Price
- MARPS $4.41
- ACXP $0.43
- Analyst Decision
- MARPS
- ACXP Strong Buy
- Analyst Count
- MARPS 0
- ACXP 2
- Target Price
- MARPS N/A
- ACXP $10.00
- AVG Volume (30 Days)
- MARPS 243.7K
- ACXP 18.4M
- Earning Date
- MARPS 01-01-0001
- ACXP 08-08-2025
- Dividend Yield
- MARPS 8.20%
- ACXP N/A
- EPS Growth
- MARPS N/A
- ACXP N/A
- EPS
- MARPS 0.36
- ACXP N/A
- Revenue
- MARPS $1,036,019.00
- ACXP N/A
- Revenue This Year
- MARPS N/A
- ACXP N/A
- Revenue Next Year
- MARPS N/A
- ACXP N/A
- P/E Ratio
- MARPS $12.12
- ACXP N/A
- Revenue Growth
- MARPS N/A
- ACXP N/A
- 52 Week Low
- MARPS $3.34
- ACXP $0.30
- 52 Week High
- MARPS $7.90
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- MARPS 48.76
- ACXP 47.99
- Support Level
- MARPS $4.20
- ACXP $0.52
- Resistance Level
- MARPS $6.46
- ACXP $0.63
- Average True Range (ATR)
- MARPS 0.89
- ACXP 0.09
- MACD
- MARPS -0.07
- ACXP 0.00
- Stochastic Oscillator
- MARPS 16.11
- ACXP 17.33
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.